Katsumichi Fujimaki

4PUBLICATIONS
6CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Pharmaceutical delivery technologiesClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Aug 05, 2026
Real-world effectiveness of fostamatinib in patients with immune thrombocytopenia: a single-center retrospective study.

|Jan 02, 2024
Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study.

Masataka Kuwana, Tomoki Ito, Shugo Kowata

|Dec 05, 2022
Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo-controlled, double-blind, parallel-group study.

Masataka Kuwana, Tomoki Ito, Shugo Kowata

|Dec 01, 2017
10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.

Katsumichi Fujimaki, Yukako Hattori, Hideaki Nakajima

Pageof 1

Frequent Collaborators

2 joint publications

Masataka Kuwana

2 joint publications

Tomoki Ito

2 joint publications

Shugo Kowata

2 joint publications

Toshiya Kagoo